vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Sphere Entertainment Co. (SPHR). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $393.8M, roughly 1.2× Sphere Entertainment Co.). Sphere Entertainment Co. runs the higher net margin — 16.4% vs -10.1%, a 26.6% gap on every dollar of revenue. Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 12.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Sphere Entertainment Co. is an American entertainment holding company based in New York City, and controlled by the family of Charles Dolan. It owns the Sphere event venue in Paradise, Nevada, in the Las Vegas Valley and New York-based regional sports network chain MSG Networks.

CLOV vs SPHR — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.2× larger
CLOV
$487.7M
$393.8M
SPHR
Higher net margin
SPHR
SPHR
26.6% more per $
SPHR
16.4%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
12.1%
SPHR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
SPHR
SPHR
Revenue
$487.7M
$393.8M
Net Profit
$-49.3M
$64.7M
Gross Margin
Operating Margin
-10.1%
7.3%
Net Margin
-10.1%
16.4%
Revenue YoY
44.7%
Net Profit YoY
-123.2%
EPS (diluted)
$2.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
SPHR
SPHR
Q4 25
$487.7M
$393.8M
Q3 25
$496.6M
$262.1M
Q2 25
$477.6M
$282.2M
Q1 25
$462.3M
$280.1M
Q4 24
$337.0M
Q3 24
$331.0M
$227.1M
Q2 24
$356.3M
$272.6M
Q1 24
$346.9M
$320.6M
Net Profit
CLOV
CLOV
SPHR
SPHR
Q4 25
$-49.3M
$64.7M
Q3 25
$-24.4M
$-101.2M
Q2 25
$-10.6M
$151.8M
Q1 25
$-1.3M
$-82.0M
Q4 24
$-22.1M
Q3 24
$-9.2M
$-105.3M
Q2 24
$7.4M
$-46.6M
Q1 24
$-19.2M
$-47.2M
Gross Margin
CLOV
CLOV
SPHR
SPHR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
SPHR
SPHR
Q4 25
-10.1%
7.3%
Q3 25
-4.9%
-49.5%
Q2 25
-2.2%
-17.8%
Q1 25
-0.3%
-28.1%
Q4 24
-6.4%
Q3 24
-2.7%
-51.8%
Q2 24
2.0%
-66.3%
Q1 24
-6.5%
-12.6%
Net Margin
CLOV
CLOV
SPHR
SPHR
Q4 25
-10.1%
16.4%
Q3 25
-4.9%
-38.6%
Q2 25
-2.2%
53.8%
Q1 25
-0.3%
-29.3%
Q4 24
-6.6%
Q3 24
-2.8%
-46.4%
Q2 24
2.1%
-17.1%
Q1 24
-5.5%
-14.7%
EPS (diluted)
CLOV
CLOV
SPHR
SPHR
Q4 25
$2.42
Q3 25
$-2.80
Q2 25
$3.39
Q1 25
$-2.27
Q4 24
Q3 24
$-2.95
Q2 24
$-1.33
Q1 24
$-1.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
SPHR
SPHR
Cash + ST InvestmentsLiquidity on hand
$78.3M
Total DebtLower is stronger
$692.7M
Stockholders' EquityBook value
$308.7M
$2.2B
Total Assets
$541.0M
$4.2B
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
SPHR
SPHR
Q4 25
$78.3M
Q3 25
$384.8M
Q2 25
$355.7M
Q1 25
$465.0M
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
$559.8M
Q1 24
$208.3M
Total Debt
CLOV
CLOV
SPHR
SPHR
Q4 25
$692.7M
Q3 25
$733.8M
Q2 25
$743.8M
Q1 25
$1.3B
Q4 24
Q3 24
$1.4B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
CLOV
CLOV
SPHR
SPHR
Q4 25
$308.7M
$2.2B
Q3 25
$340.9M
$2.2B
Q2 25
$344.2M
$2.3B
Q1 25
$336.1M
$2.1B
Q4 24
$341.1M
Q3 24
$342.2M
$2.3B
Q2 24
$324.9M
$2.4B
Q1 24
$292.5M
$2.4B
Total Assets
CLOV
CLOV
SPHR
SPHR
Q4 25
$541.0M
$4.2B
Q3 25
$559.7M
$4.1B
Q2 25
$575.0M
$4.2B
Q1 25
$583.7M
$4.4B
Q4 24
$580.7M
Q3 24
$653.0M
$4.6B
Q2 24
$674.2M
Q1 24
$671.8M
$4.9B
Debt / Equity
CLOV
CLOV
SPHR
SPHR
Q4 25
0.31×
Q3 25
0.34×
Q2 25
0.32×
Q1 25
0.62×
Q4 24
Q3 24
0.59×
Q2 24
0.57×
Q1 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
SPHR
SPHR
Operating Cash FlowLast quarter
$-66.9M
$180.2M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
2.78×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
SPHR
SPHR
Q4 25
$-66.9M
$180.2M
Q3 25
$12.1M
$115.8M
Q2 25
$5.4M
$-59.1M
Q1 25
$-16.3M
$6.3M
Q4 24
$34.8M
Q3 24
$50.0M
$34.1M
Q2 24
$44.8M
$-72.4M
Q1 24
$25.9M
$101.0M
Free Cash Flow
CLOV
CLOV
SPHR
SPHR
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
SPHR
SPHR
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
SPHR
SPHR
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
SPHR
SPHR
Q4 25
2.78×
Q3 25
Q2 25
-0.39×
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

SPHR
SPHR

Ticketing And Venue License Fee Revenues$198.5M50%
Media Networks Revenue$120.1M30%
Sponsorship Signage Exosphere Advertising And Suite Licenses$32.2M8%
Food Beverage And Merchandise Revenues$27.6M7%
Other$13.2M3%
Related Party$2.3M1%

Related Comparisons